Results 101 to 110 of about 16,205 (199)

Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD

open access: yesTherapeutic Advances in Gastroenterology, 2017
Background: Thiopurines, azathioprine (AZA) and 6-mercaptopurine (6-MP) are common maintenance medications for inflammatory bowel disease (IBD).
Brigitte Moreau   +3 more
doaj   +1 more source

Beyond the Skin: Can Genetic Variants Predict Crohn's Disease in Psoriasis Patients?

open access: yes
International Journal of Dermatology, Volume 65, Issue 3, Page 425-426, March 2026.
Yuval Ramot
wiley   +1 more source

Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values

open access: yesBMC Research Notes, 2018
Objectives This study assessed the activity of thiopurine S-methyltransferase (TPMT) in Nigerians with a view to providing data on susceptibility to thiopurine toxicity, and as well generate reference activity values for clinical use.
Ayorinde Adehin, Oluseye O. Bolaji
doaj   +1 more source

Thiopurines inhibit bovine viral diarrhea virus production in a thiopurine methyltransferase-dependent manner

open access: yesJournal of General Virology, 2008
The family Flaviviridae comprises positive-strand RNA viral pathogens of humans and livestock with few treatment options. We have previously shown that azathioprine (AZA) has in vitro activity against bovine viral diarrhea virus (BVDV). While the mechanism of inhibition is unknown, AZA and related thiopurine nucleoside analogues have been used as ...
Spencer, Hoover, Rob, Striker
openaire   +2 more sources

The Role of Laboratory Tests in Crohn's Disease

open access: yesClinical Medicine Insights: Gastroenterology, 2016
In the past, laboratory tests were considered of limited value in Crohn's disease (CD). In the era of biologics, laboratory tests have become essential to evaluate the inflammatory burden of the disease (C-reactive protein, fecal calprotectin) since ...
Maria Cappello   +1 more
doaj   +1 more source

Personalised medicine, unmet need or business strategy?

open access: yes, 2013
Personalised medicine is a discipline that integrates pharmaceutical development with existing knowledge about the genetic and phenotypic factors that influence drug response.
Sáinz de la Fuente, G. (Graciela)
core  

Association between the c.415C > T, c.52G > A, and 36_37insGGAGTC polymorphisms of NUDT 15 and thiopurine-induced leukopenia, thiopurine intolerance, and severe hair loss: an updated meta-analysis

open access: yesDrug Design, Development and Therapy, 2019
Ruili Wang,1,2 Baogang Liu,2 Jiapeng Li,1 Jiamin Xu,1 Xiaoling Wang,1 Zhigang Zhao,2 Libo Zhao11Clinical Research Center, Beijing Children’s Hospital, National Center for Children’s Health, Capital Medical University, Beijing, People’s ...
Wang R   +6 more
doaj  

Development of a Scalable Pharmacogenomic Clinical Decision Support Service [PDF]

open access: yes, 2014
Advances in sequencing technology are making genomic data more accessible within the healthcare environment. Published pharmacogenetic guidelines attempt to provide a clinical context for specific genomic variants; however, the actual implementation to ...
Brownstein, Catherine   +7 more
core  

Liver transplantation [PDF]

open access: yes, 2014
Purpose of review: Long-term survival of liver transplant recipients is threatened by increased rates of de-novo malignancy and recurrence of hepatocellular carcinoma (HCC), both events tightly related to immunosuppression.
Burroughs, AK   +2 more
core  

Home - About - Disclaimer - Privacy